2,4,6-tribromo-3-hydroxybenzoic acid has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moshides, JS | 1 |
1 other study(ies) available for 2,4,6-tribromo-3-hydroxybenzoic acid and Coronary Disease
| Article | Year |
|---|---|
Enzymic determination of the free cholesterol fraction of high-density lipoprotein in plasma with use of 2,4,6-tribromo-3-hydroxybenzoic acid.
Topics: Adult; Aged; Ampyrone; Autoanalysis; Bromobenzoates; Cholesterol; Cholesterol Oxidase; Cholesterol, HDL; Coronary Disease; Female; Humans; Hydrogen-Ion Concentration; Hydroxybenzoates; Male; Middle Aged; Peroxidase; Polyethylene Glycols; Quality Control; Reference Values; Regression Analysis; Spectrophotometry | 1988 |